abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página no está disponible en Español y está siendo mostrada en English

Artículo

29 Oct 2008

Autor:
Soutik Biswas, BBC

Indian drugs boss hails Aids deal

Three years ago, Yusuf K Hamied, head of Indian drugs company Cipla, stunned a European Commission medical meeting in Brussels by offering to sell anti-Aids drugs at a fraction of the going rate...Last week, Dr Hamied won a major victory when former US president Bill Clinton brokered a deal whereby four companies making cheap, generic Aids drugs could begin supplying to millions of people in developing countries...one of them is Cipla, India's third largest drug company.

Línea del tiempo